Cargando…

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate

For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy leads to improved progression free survival but attempts to deliver increased dose by external beam radiation therapy (EBRT) alone can be limited by late toxicities to nearby genitourinary and gastrointestin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer-Valuck, Benjamin W., Gay, Hiram A., Patel, Sagar, Baumann, Brian C., Michalski, Jeff M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6914687/ https://www.ncbi.nlm.nih.gov/pubmed/31921640 http://dx.doi.org/10.3389/fonc.2019.01378

Ejemplares similares

Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
por: Barnes, Justin, et al.
Publicado: (2019)

The use of nomograms in LDR-HDR prostate brachytherapy
por: Pujades, Ma Carmen, et al.
Publicado: (2011)

High Dose Rate (HDR) Brachytherapy for Mycosis Fungoides of the Wrist
por: Shukla, Gaurav, et al.
Publicado: (2015)

The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer
por: Yoshioka, Yasuo, et al.
Publicado: (2013)

Is there any place for LDR brachytherapy for head and neck carcinomas in HDR era?
por: Fijuth, Jacek
Publicado: (2009)

Langzeitauswertung der Low-dose-rate(LDR)-Brachytherapie des lokal begrenzten Prostatakarzinoms
por: Carl, N., et al.
Publicado: (2023)

High dose rate (HDR) brachytherapy quality assurance: a practical guide
por: Wilkinson, DA
Publicado: (2006)

Validity study of educational technology on gynecological high dose rate (HDR) brachytherapy
por: Ximenes, Meiriane Lopes, et al.
Publicado: (2023)

HDR and LDR Brachytherapy in the Treatment of Lip Cancer: the Experience of the Catalan Institute of Oncology
por: Ayerra, Arrate Querejeta, et al.
Publicado: (2010)

Low‐Dose‐Rate Prostate Brachytherapy (LDR‐PB) adopts postsurgical PSA value for definition of cure
por: Uribe, Jennifer, et al.
Publicado: (2020)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Perioperative high dose rate (HDR) brachytherapy in unresectable locally advanced pancreatic tumors
por: Waniczek, Dariusz, et al.
Publicado: (2011)

A survey of quality control practices for high dose rate (HDR) and pulsed dose rate (PDR) brachytherapy in the United Kingdom
por: Palmer, Antony L, et al.
Publicado: (2012)

Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2020)

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique
por: Morton, Gerard C.
Publicado: (2014)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

A Report on the Clinical Outcome after High-Dose Rate (HDR) Brachytherapy as Monotherapy in Early Prostate Cancer
por: Potharaju, Mahadev, et al.
Publicado: (2015)

Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020)

Impact of point A asymmetry on local control and survival for low dose-rate (LDR) brachytherapy in cervical cancer
por: Opfermann, Krisha J, et al.
Publicado: (2012)

Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost
por: Chicheł, Adam, et al.
Publicado: (2009)

Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis
por: Roy, Amit, et al.
Publicado: (2021)

Interstitial high-dose rate brachytherapy as boost for anal canal cancer
por: Falk, Alexander Tuan, et al.
Publicado: (2014)

Comparison of single and multiple dwell position methods in MammoSite high dose rate (HDR) brachytherapy planning
por: Kim, Yongbok, et al.
Publicado: (2010)

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer
por: Olsén, Johan Staby, et al.
Publicado: (2022)

Dose correction in lung for HDR breast brachytherapy
por: Slessinger, Eric, et al.
Publicado: (2012)

Evaluation of hybrid inverse planning and optimization (HIPO) algorithm for optimization in real‐time, high‐dose‐rate (HDR) brachytherapy for prostate
por: Pokharel, Shyam, et al.
Publicado: (2013)

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer
por: Tanaka, Nobumichi, et al.
Publicado: (2012)

Dosimetric evaluation of a novel high dose rate (HDR) intraluminal / interstitial brachytherapy applicator for gastrointestinal and bladder cancers
por: Tabrizi, Sanaz Hariri, et al.
Publicado: (2010)

Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma
por: Walter, Franziska, et al.
Publicado: (2021)

The Association of Radiation Dose With Overall Survival for Patients Treated With Prostate Stereotactic Body Radiation Therapy
por: Waters, Michael R, et al.
Publicado: (2023)

Physics-aspects of dose accuracy in high dose rate (HDR) brachytherapy: source dosimetry, treatment planning, equipment performance and in vivo verification techniques
por: Palmer, Antony, et al.
Publicado: (2012)

MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
por: Ménard, Cynthia, et al.
Publicado: (2022)

Basal Cell Carcinoma Treated with High Dose Rate (HDR) Brachytherapy—Early Evaluation of Clinical and Dermoscopic Patterns during Irradiation
por: Krzysztofiak, Tomasz, et al.
Publicado: (2021)

Dosimetric Superiority of High-Dose-Rate (HDR) Brachytherapy Using a Surface Mold Applicator for Primary Cutaneous Angiosarcoma of the Scalp
por: Takase, Kei, et al.
Publicado: (2022)

High dose-rate brachytherapy in the treatment of prostate cancer
por: Mendez, Lucas C., et al.
Publicado: (2018)

Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer – between options
por: Skowronek, Janusz
Publicado: (2013)

Prevention of high-dose-rate brachytherapy accidents
por: Commission Internationale de Protection contre les Radiations
Publicado: (2005)

High Dose Rate Brachytherapy - A Textbook
por: Ash, DV
Publicado: (1995)

High dose rate brachytherapy for oral cancer
por: YamazakI, Hideya, et al.
Publicado: (2013)

Obstructive urination problems after high-dose-rate brachytherapy boost treatment for prostate cancer are avoidable
por: Kragelj, Borut
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_43sckugt8jdddt0lcbmd2j69hd